Study shows bioavailable form of Ferric Pyrophosphate from Taiyo is safe and effective for pregnant women
A recently published study investigated the impact of 30 mg tablets of SunActive Fe Emulsified Microsomal Ferric Pyrophosphate (EMFP) for the treatment of Iron Deficiency Anemia (IDA) in pregnant women.
Photo © AdobeStock.com/nataliaderiabina
A recent study published in Cureus1 investigated the impact of 30 mg tablets of SunActive Fe Emulsified Microsomal Ferric Pyrophosphate (EMFP) for the treatment of Iron Deficiency Anemia (IDA) in pregnant women. The ingredient is manufactured by Taiyo Kagaku, Japan. In the study, 27 pregnant women in their second trimester with IDA were given 30 mg of SunActive Fe for 30 days.
Results showed that compared to baseline, serum ferritin levels exhibited a 6.61-fold increase, and that elevated levels were maintained consistently. Additionally, serum iron increased significantly by 46.9% while symptoms such as nausea, breathlessness, dizziness, irritability, and heartburn saw notable reductions, improving the pregnant women’s quality of life.
“This work is especially important because there are several types of encapsulated irons, but none have been shown to be safe or effective in pregnant women,” said the study’s lead author Alok Shah, PhD, in a press release. Shah is on the faculty at the University of Chicago. “This study is groundbreaking because it cuts through the noise created by marketing and presents the science on its merit,” he added, “It clearly shows that SunActive Fe is an exceptional safe and efficacious oral anemia treatment.”
According to a press release from Generex Pharmassist Pvt. Ltd., a “techno-marketing” company that in-licenses clinically backed patented ingredients for the Indian pharmaceutical, nutraceutical, over-the-counter, and direct-to-consumer markets, SunActive Fe ismicroencapsulated using Taiyo’s proprietary Advanced Microsomal Technology, making it more bioavailable. The patented EMFP also has a very small particle size, allowing it to be directly absorbed by a special class of intestinal cells, called M cells. Shah is also the head of science and technical marketing for Generex.
Reference
- Srivastav, A.; Kshirsagar, S.; Adhav, T.; Ganu, G.; Shah, A. Efficacy and Safety of Microsomal Ferric Pyrophosphate Supplement for Iron Deficiency Anemia in Pregnancy. Cureus. 2024, 16 (3), e57108. DOI: 10.7759/cureus.57108
